4 Schizophrenia Clinical Trials in Glen Oaks, NY (2026)

Q: How do I join a clinical trial in Glen Oaks?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Glen Oaks research site will contact you.

Recruiting Schizophrenia Studies in Glen Oaks

NCT07226895Recruiting

A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis

The goal of this clinical trial is to learn how tests undertaken by people at high risk of developing psychosis (aged 17 to 30 years old) change when those people are given the study drug MT1988 daily...

Glen Oaks, NY150 participantsMonument Therapeutics Limited

View Study Details

NCT07483294Recruiting

Cerebellum-based Imaging Neural Markers for Antipsychotic Response

This study plans to collect 120 patients with first-episode psychosis. Participants will receive multimodal MRI scans (naturalistic fMRI, structural, diffusional) and comprehensive clinical assessment...

Glen Oaks, NY120 participantsNorthwell Health

View Study Details

NCT06118268Recruiting

iTBS to Enhance Social Cognition in People With Psychosis

The goal of this clinical trial is to examine if iTBS applied to the DMPFC improves social cognitive performance compared to sham stimulation in people diagnosed with schizophrenia, schizoaffective di...

Glen Oaks, NY100 participantsNorthwell Health

View Study Details

NCT05131035Recruiting

Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis Risk

This 10 week intervention, Specific Cognitive Remediation with Surround (or SCORES), is designed to target processing speed, a cognitive domain related directly to social functioning, which in turn, r...

Glen Oaks, NY54 participantsNorthwell Health

View Study Details

About Schizophrenia Clinical Trials in Glen Oaks

Schizophrenia is a chronic brain disorder affecting approximately 2.8 million US adults, characterized by hallucinations, delusions, disorganized thinking, and cognitive difficulties. While current treatments rely primarily on first- and second-generation antipsychotics (risperidone, olanzapine, clozapine), many patients experience incomplete symptom relief or significant side effects. Clinical trials are testing novel mechanisms including muscarinic receptor agonists (like KarXT/xanomeline-trospium), trace amine-associated receptor 1 (TAAR1) agonists, glutamate modulators, and long-acting injectable formulations. Treatment-resistant schizophrenia remains a major focus area, with trials seeking patients who have not adequately responded to standard antipsychotic therapy.

There are currently 4 schizophrenia clinical trials recruiting participants in Glen Oaks, NY. These studies are seeking a combined 424 participants. Research is being sponsored by Monument Therapeutics Limited, Northwell Health. Clinical trial participation is free and participants receive study-related medical care at no cost.

Schizophrenia Clinical Trials in Glen Oaks — FAQ

Are there schizophrenia clinical trials in Glen Oaks?

Yes, there are 4 schizophrenia clinical trials currently recruiting in Glen Oaks, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Glen Oaks?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Glen Oaks research site will contact you about next steps.

Are clinical trials in Glen Oaks free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Glen Oaks studies also compensate for your time and travel.

What schizophrenia treatments are being tested?

The 4 active trials in Glen Oaks are testing new therapies including novel drugs, biologics, and treatment approaches for schizophrenia.

Data updated July 13, 2026 from ClinicalTrials.gov